Literature DB >> 2722480

Prompt elevations of PGE2 and thromboxane A2 metabolites in peripheral node efferent lymph of sheep following drainage area immunization.

T C Moore1, C H Spruck, J L Lami, S I Said.   

Abstract

In the past decade, the main interest in the involvement of prostaglandin E2 (PGE2) in the immune response has been concerned with its role in immunomodulation (suppression) both in vitro and in vivo. Comparatively little attention has been devoted to its immunostimulatory role. It has been suggested that PGE2, like histamine, may function as a 'double agent', initially triggering, facilitating and augmenting a stimulatory immune response and later modulating, limiting and contributing to the turning off of this response. We here report an early (within minutes) immunostimulatory involvement of PGE2 (and thromboxane A2) in the sheep, with prompt elevations in levels of PGE2 and thromboxane B2 in popliteal lymph node efferent lymph following drainage area immunization with killed Salmonella muenchen bacteria. These elevations were associated with an increase in efferent lymph flow and an equally prompt but limited depression of lymphocyte outputs into efferent lymph ('shutdown', 'recruitment'). Local increases in blood flow and vascular permeability probably play important roles in these events.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722480     DOI: 10.1016/0162-3109(89)90052-0

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  2 in total

1.  Effect of interleukin 2 on urinary excretion of degradation products of prostacyclin and thromboxane A2 in patients with ovarian cancer.

Authors:  A Aitokallio-Tallberg; P Lehtovirta; J Vartiainen; O Ylikorkala
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

2.  Thromboxane A2 acts as tonic immunoregulator by preferential disruption of low-avidity CD4+ T cell-dendritic cell interactions.

Authors:  Federica Moalli; Jovana Cupovic; Flavian Thelen; Pascal Halbherr; Yoshinori Fukui; Shuh Narumiya; Burkhard Ludewig; Jens V Stein
Journal:  J Exp Med       Date:  2014-12-08       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.